Clinical Trial Update: A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Update on a Phase 2 safety PK/PD trial of SLV337 in patients with Type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SLV337

Snippet

Sponsor: Abbott Products | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED